LOBEF (Lobe Sciences) Pretax Margin %: % (As of Feb. 2026)


What is Lobe Sciences Pretax Margin %?

Lobe Sciences LOBEF -7.24% Pretax Margin % is % as of Feb. 2026. The stock has 2 warning signs investors should review. Among 945 Biotechnology companies, Lobe Sciences ranks worse than 105820% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Lobe Sciences's Pre-Tax Income for the three months ended in Feb. 2026 was $-1.75 Mil. Lobe Sciences's Revenue for the three months ended in Feb. 2026 was $0.00 Mil. Therefore, Lobe Sciences's pretax margin for the quarter that ended in Feb. 2026 was %.

The historical rank and industry rank for Lobe Sciences's Pretax Margin % or its related term are showing as below:


LOBEF's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.63
* Ranked among companies with meaningful Pretax Margin % only.

Lobe Sciences  (OTCPK:LOBEF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Lobe Sciences Pretax Margin % Related Terms

Lobe Sciences Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Lobe Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences Pretax Margin % Chart

Lobe Sciences Annual Data
Trend Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -535.26 -3,213.00 0.00

Lobe Sciences Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LOBEF vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Lobe Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lobe Sciences Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's Pretax Margin % falls into.


Lobe Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Lobe Sciences's Pretax Margin for the fiscal year that ended in Aug. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Aug. 2025 )/Revenue (A: Aug. 2025 )
=-3.524/0
= %

Lobe Sciences's Pretax Margin for the quarter that ended in Feb. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-1.75/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Lobe Sciences (LOBEF) has a Pretax Margin % of % as of Feb. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Lobe Sciences and its competitors. According to the industry distribution chart, Lobe Sciences ranks #999999 out of 945 companies in the Biotechnology industry.
Is Lobe Sciences' Pretax Margin % too high?
Lobe Sciences' current Pretax Margin % is %. Based on the distribution chart, Lobe Sciences ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Lobe Sciences' Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lobe Sciences ranks #999999 out of 945 companies for Pretax Margin %. This places Lobe Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Lobe Sciences and its competitors. Lobe Sciences's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current Pretax Margin % is % as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lobe Sciences Business Description

Other Exchanges LOBE:GermanyLOBE:Canada
Address 1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.